Today we live, Together we fight

Transcription

Today we live, Together we fight
Today we live,
Together we fight
Today, Together
JOIN THE MOVEMENT AND SHOW YOUR SUPPORT
BY HELPING US R AISE AWARENESS ABOUT
CHRONIC MYELOID LEUKEMIA, A R ARE CANCER.
UR LOF S I T E .COM
PLEA SE
IN SERT YOUR
LOGO HERE
Yes, it’s leukemia,
it’s cancer.
But if treated effectively with
recommended treatments, patients
with chronic myeloid leukemia (CML)
today can have a life expectancy similar
to that of the general population.
While medicine has provided us with
the weapon we need to live and enjoy
a good quality of life, it is still
an ongoing fight to help each patient
access treatment.
[Space for localization/adding local organization’s story…
for example: Right here in Spain, there are XYZ patients
IMAGE
PLACEHOLDER
who don’t want to struggle with CML. And we are fighting
to change that.]
Join the movement for access to treatment
for this rare cancer today and together with
all of us and help raise awareness on
VENUE
WHERE
Name of venue
Lorem Ipsum Road, 161
XXXX, City Name
Country
Alis sequias dendes simi, nes sunt eosedi
blam, consequo consequibus.
www.urleventname.com
twitter.com/eventname
facebook.com/eventname
Chronic myeloid
leukemia (CML)
CML is a rare cancer that is characterized
by an unregulated growth of white
blood cells in the bone marrow and the
accumulation of these cells in the blood.
Even though there has been a medical
revolution in treating CML over the past
decade, not every patient has access to the
best available treatment and care. Those
who have access struggle to live with CML
as a chronic, life-long disease. Without
treatment life expectancy is three years.
Contact Name +3 4 9 15 6 318 0 1
World CML Day
Initiated by the patient community in 2008, September 22 (9/22) has
marked World CML Day because of its symbolic significance – the disease
is caused by the change of chromosomes 9 and 22. On this day, patients
across the globe come together to raise awareness about their needs to
the general public, politicians, and medical professionals across the world.
The CML Advocates Network
The CML Advocates Network is a global non-profit community run by
patients in roughly 80 countries. Launched in 2007 by four founding
organizations, it now consists of more than 100 patient groups,
offering support by sharing best practices, information, and advice for
CML patient advocates. Find out more at http://cmladvocates.net

Similar documents

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Size, Causes, Outlook, Overview and Pipeline Review, H1 2016

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Size, Causes, Outlook, Overview and Pipeline Review, H1 2016 Global Markets Direct's, 'Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016', provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape. Visit Us @ http://www.radiantinsights.com/research/chronic-myelocytic-leukemia-cml-chronic-myeloid-leukemia-pipeline-review-h1-2016

More information